RENO, Nev.--(BUSINESS WIRE)--March 16, 2006--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) announced today that the Company has reduced their outstanding debt by $300,000. The company’s management and advisors have converted amounts due to them into shares of Lifeline Biotechnologies common stock. The company has reduced its debt by more than $500,000 over the last three months.
